Cargando…
Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections
Airway mucus dysfunction and impaired immunological defenses are hallmarks of several lung diseases, including asthma, cystic fibrosis, and chronic obstructive pulmonary diseases, and are mostly causative factors in bacterial-biofilm-associated respiratory tract infections. Bacteria residing within...
Autores principales: | Guo, Yutong, Mao, Zeyuan, Ran, Fang, Sun, Jihong, Zhang, Jingfeng, Chai, Guihong, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674810/ https://www.ncbi.nlm.nih.gov/pubmed/38004561 http://dx.doi.org/10.3390/pharmaceutics15112582 |
Ejemplares similares
-
Recent advances in nanotechnology for eradicating bacterial biofilm
por: Sahli, Célia, et al.
Publicado: (2022) -
Nanotechnology-based drug delivery systems for control of microbial biofilms: a review
por: Dos Santos Ramos, Matheus Aparecido, et al.
Publicado: (2018) -
Nanotechnology in Advanced Drug Delivery
por: Jain, Sanyog, et al.
Publicado: (2011) -
Nanotechnology in drug and gene delivery
por: Hamimed, Selma, et al.
Publicado: (2022) -
Nanotechnology in Targeted Drug Delivery
por: Di Stefano, Antonio
Publicado: (2023)